Search Results - "Kunju, Priya"

Diagnostic Criteria for Oncocytic Renal Neoplasms: A Survey of Urologic Pathologists by Williamson, Sean R, MD, Gadde, Ramya, MD, Trpkov, Kiril, MD, Hirsch, Michelle S., MD, PhD, Srigley, John R, MD, Reuter, Victor E, MD, Cheng, Liang, MD, Priya Kunju, L, MD, Barod, Ravi, MD, Rogers, Craig G, MD, Delahunt, Brett, MD, Hes, Ondrej, MD, Eble, John N, MD, Zhou, Ming, MD, PhD, McKenney, Jesse K, MD, Martignoni, Guido, MD, Fleming, Stewart, MD, Grignon, David J, MD, Moch, Holger, MD, Gupta, Nilesh S, MD

“…Summary Renal oncocytoma and chromophobe renal cell carcinoma (RCC) have been long recognized as distinct tumors; however, it remains unknown if uniform…”
Get full text

AI reality check when evaluating difficult to grade prostate cancers by Pantanowitz, Liron, Mehra, Rohit, Kunju, L. Priya

Get full text

Differentiation of papillary renal cell carcinoma subtypes on CT and MRI by Egbert, Nathan D, Caoili, Elaine M, Cohan, Richard H, Davenport, Matthew S, Francis, Isaac R, Kunju, L Priya, Ellis, James H

“…The objective of our study was to determine the frequency of atypical papillary renal cell carcinomas (RCCs) and identify imaging differences between type 1…”
Get full text

Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin by Sangoi, Ankur R., Chan, Emily, Stohr, Bradley A., Kunju, L. Priya

“…Invasive plasmacytoid urothelial carcinomas (PUCs) are an uncommon aggressive variant, which often shows immunohistochemical loss of E-cadherin, underlying its…”
Get full text

ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer by Lorenzatti Hiles, Guadalupe, Bucheit, Amanda, Rubin, John R, Hayward, Alexandra, Cates, Angelica L, Day, Kathleen C, El-Sawy, Layla, Kunju, L Priya, Daignault, Stephanie, Lee, Cheryl T, Liebert, Monica, Hussain, Maha, Day, Mark L

“…ADAM15 is a member of a family of catalytically active disintegrin membrane metalloproteinases that function as molecular signaling switches, shed membrane…”
Get full text

Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections by Spratt, Daniel E., Suresh, Krithika, Osawa, Takahiro, Schipper, Matthew, Jackson, William C., Abugharib, Ahmed, Lebastchi, Amir, Smith, David, Montgomery, Jeffrey S., Palapattu, Ganesh S., Priya Kunju, L., Wu, Angela, Lew, Madelyn, Tomlins, Scott A., Chinnaiyan, Arul M., Weizer, Alon Z., Hafez, Khaled S., Kaffenberger, Samuel D., Udager, Aaron, Mehra, Rohit

“…The frequency of co-occurrence between germ cell tumor (GCT) components in non-seminomatous germ cell tumor (NSGCT) orchiectomy specimens and their correlation…”
Get full text

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth by Mody, Rajen J, Wu, Yi-Mi, Lonigro, Robert J, Cao, Xuhong, Roychowdhury, Sameek, Vats, Pankaj, Frank, Kevin M, Prensner, John R, Asangani, Irfan, Palanisamy, Nallasivam, Dillman, Jonathan R, Rabah, Raja M, Kunju, Laxmi Priya, Everett, Jessica, Raymond, Victoria M, Ning, Yu, Su, Fengyun, Wang, Rui, Stoffel, Elena M, Innis, Jeffrey W, Roberts, J. Scott, Robertson, Patricia L, Yanik, Gregory, Chamdin, Aghiad, Connelly, James A, Choi, Sung, Harris, Andrew C, Kitko, Carrie, Rao, Rama Jasty, Levine, John E, Castle, Valerie P, Hutchinson, Raymond J, Talpaz, Moshe, Robinson, Dan R, Chinnaiyan, Arul M

“…IMPORTANCE: Cancer is caused by a diverse array of somatic and germline genomic aberrations. Advances in genomic sequencing technologies have improved the…”
Get full text

Urothelial Carcinoma with Divergent Histologic Differentiation (Mixed Histologic Features) Predicts the Presence of Locally Advanced Bladder Cancer When Detected at Transurethral Resection by Wasco, Matthew J, Daignault, Stephanie, Zhang, Yingxi, Kunju, Lakshmi Priya, Kinnaman, Michael, Braun, Thomas, Lee, Cheryl T, Shah, Rajal B

“…Objectives The histologic classification of bladder tumors remains an important predictor of treatment response and patient outcome, with pure nonurothelial…”
Get full text

Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non―Muscle-Invasive Bladder Cancer by ROU WANG, MORRIS, David S, CHINNAIYAN, Arul M, TOMLINS, Scott A, LONIGRO, Robert J, TSODIKOV, Alexander, MEHRA, Rohit, GIORDANO, Thomas J, PRIYA KUNJU, L, LEE, Cheryl T, WEIZER, Alon Z

“…In bladder cancer, clinical grade and stage fail to capture outcome. We developed a clinically applicable quantitative PCR (QPCR) gene signature to predict…”
Get full text

Urethral Cancer by Grivas, Petros D., MD, PhD, Davenport, Matthew, MD, Montie, James E., MD, Kunju, L. Priya, MD, Feng, Felix, MD, PhD, Weizer, Alon Z., MD, MS

“…Urethral carcinoma is a rare tumor with predominantly poor survival. Both the disease and its treatment can affect both sexual and urinary function. The…”
Get full text

Characterization of glycine‐N‐acyltransferase like 1 (GLYATL1) in prostate cancer by Eich, Marie‐Lisa, Chandrashekar, Darshan Shimoga, Rodriguez Pen᷉a, Maria Del Carmen, Robinson, Alyncia D., Siddiqui, Javed, Daignault‐Newton, Stephanie, Chakravarthi, Balabhadrapatruni V. S. K., Kunju, Lakshmi Priya, Netto, George J., Varambally, Sooryanarayana

“…Background Recent microarray and sequencing studies of prostate cancer showed multiple molecular alterations during cancer progression. It is critical to…”
Get full text

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment by Tomlins, Scott A, Day, John R, Lonigro, Robert J, Hovelson, Daniel H, Siddiqui, Javed, Kunju, L. Priya, Dunn, Rodney L, Meyer, Sarah, Hodge, Petrea, Groskopf, Jack, Wei, John T, Chinnaiyan, Arul M

“…Abstract Background TMPRSS2:ERG (T2:ERG) and prostate cancer antigen 3 (PCA3) are the most advanced urine-based prostate cancer (PCa) early detection…”
Get full text

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer by Epstein, Jonathan I, Amin, Mahul B, Fine, Samson W, Algaba, Ferran, Aron, Manju, Baydar, Dilek E, Beltran, Antonio Lopez, Brimo, Fadi, Cheville, John C, Colecchia, Maurizio, Comperat, Eva, da Cunha, Isabela Werneck, Delprado, Warick, DeMarzo, Angelo M, Giannico, Giovanna A, Gordetsky, Jennifer B, Guo, Charles C, Hansel, Donna E, Hirsch, Michelle S, Huang, Jiaoti, Humphrey, Peter A, Jimenez, Rafael E, Khani, Francesca, Kong, Qingnuan, Kryvenko, Oleksandr N, Kunju, L Priya, Lal, Priti, Latour, Mathieu, Lotan, Tamara, Maclean, Fiona, Magi-Galluzzi, Cristina, Mehra, Rohit, Menon, Santosh, Miyamoto, Hiroshi, Montironi, Rodolfo, Netto, George J, Nguyen, Jane K, Osunkoya, Adeboye O, Parwani, Anil, Robinson, Brian D, Rubin, Mark A, Shah, Rajal B, So, Jeffrey S, Takahashi, Hiroyuki, Tavora, Fabio, Tretiakova, Maria S, True, Lawrence, Wobker, Sara E, Yang, Ximing J, Zhou, Ming, Zynger, Debra L, Trpkov, Kiril

“…Controversies and uncertainty persist in prostate cancer grading. To update grading recommendations. Critical review of the literature along with pathology and…”
Get full text

The Anatomic Pathology Hospitalist Model by Chapel, Ellen E, Chapel, David B, Kunju, L Priya, Hamilton, John A, Myers, Jeffrey L, Pantanowitz, Liron

“…Challenges to staffing a high-quality frozen section service include consolidation of health systems and pathology practices, off-campus relocation of some…”
Get full text

p53 null phenotype is a “positive result” in urothelial carcinoma in situ by Sangoi, Ankur R., Chan, Emily, Abdulfatah, Eman, Stohr, Bradley A., Nguyen, Jane, Trpkov, Kiril, Siadat, Farshid, Hirsch, Michelle, Falzarano, Sara, Udager, Aaron M., Kunju, L. Priya

“…The concept of a “p53 null phenotype” (complete loss of staining) is well-recognized in the gynecologic pathology literature, implicitly reflecting that this…”
Get full text

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists by Mohanty, Sambit K., Lobo, Anandi, Jha, Shilpy, Sangoi, Ankur R., Akgul, Mahmut, Trpkov, Kiril, Hes, Ondrej, Mehra, Rohit, Hirsch, Michelle S., Moch, Holger, Smith, Steven C., Shah, Rajal B., Cheng, Liang, Amin, Mahul B., Epstein, Jonathan I., Parwani, Anil V., Delahunt, Brett, Desai, Sangeeta, Przybycin, Christopher G., Manini, Claudia, Luthringer, Daniel J., Sirohi, Deepika, Jain, Deepika, Midha, Divya, Jain, Ekta, Maclean, Fiona, Giannico, Giovanna A., Paner, Gladell P., Martignoni, Guido, Al-Ahmadie, Hikmat A., McKenney, Jesse, Srigley, John R., Lopez, Jose Ignacio, Kunju, L. Priya, Browning, Lisa, Aron, Manju, Picken, Maria M., Tretiakova, Maria, Zhou, Ming, Sable, Mukund, Kuroda, Naoto, Pattnaik, Niharika, Gupta, Nilesh S., Rao, Priya, Fine, Samson W., Mishra, Pritinanda, Adhya, Amit K., Kulkarni, Bijal N., Dixit, Mallika, Baisakh, Manas R., Arora, Samriti, Sancheti, Sankalp, Menon, Santosh, Wobker, Sara E., Tickoo, Satish K., Kaushal, Seema, Soni, Shailesh, Kandukuri, Shivani, Sharma, Shivani, Mitra, Suvradeep, Reuter, Victor E., Malik, Vipra, Rao, Vishal, Chen, Ying-Bei, Williamson, Sean R.

“…Oncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising…”
Get full text

Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification by Hipp, Jason, Monaco, James, Kunju, L Priya, Cheng, Jerome, Yagi, Yukako, Rodriguez-Canales, Jaime, Emmert-Buck, Michael R, Hewitt, Stephen, Feldman, Michael D, Tomaszewski, John E, Toner, Mehmet, Tompkins, Ronald G, Flotte, Thomas, Lucas, David, Gilbertson, John R, Madabhushi, Anant, Balis, Ulysses

“…INTRODUCTIONThe advent of digital slides offers new opportunities within the practice of pathology such as the use of image analysis techniques to facilitate…”
Get full text

Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications by Piert, Morand, Shankar, Prasad R., Montgomery, Jeffrey, Kunju, Lakshmi Priya, Rogers, Virginia, Siddiqui, Javed, Rajendiran, Thekkelnaycke, Hearn, Jason, George, Arvin, Shao, Xia, Davenport, Matthew S.

“…Background The study aims to assess the accuracy of multi-parametric prostate MRI (mpMRI) and 18 F-choline PET/CT in tumor segmentation for clinically…”
Get full text

Poster Session by Hipp, Jason, Smith, Steven Christopher, Cheng, Jerome, Tomlins, Scott, Monaco, James, Madabhushi, Anant, Kunju, Priya, Balis, Ulysses J.

Get full text

Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey by Fine, Samson W., Trpkov, Kiril, Amin, Mahul B., Algaba, Ferran, Aron, Manju, Baydar, Dilek E., Beltran, Antonio Lopez, Brimo, Fadi, Cheville, John C., Colecchia, Maurizio, Comperat, Eva, Costello, Tony, da Cunha, Isabela Werneck, Delprado, Warick, DeMarzo, Angelo M., Giannico, Giovanna A., Gordetsky, Jennifer B., Guo, Charles C., Hansel, Donna E., Hirsch, Michelle S., Huang, Jiaoti, Humphrey, Peter A., Jimenez, Rafael E., Khani, Francesca, Kong, Max X., Kryvenko, Oleksandr N., Kunju, L. Priya, Lal, Priti, Latour, Mathieu, Lotan, Tamara, Maclean, Fiona, Magi-Galluzzi, Cristina, Mehra, Rohit, Menon, Santosh, Miyamoto, Hiroshi, Montironi, Rodolfo, Netto, George J., Nguyen, Jane K., Osunkoya, Adeboye O., Parwani, Anil, Pavlovich, Christian P., Robinson, Brian D., Rubin, Mark A., Shah, Rajal B., So, Jeffrey S., Takahashi, Hiroyuki, Tavora, Fabio, Tretiakova, Maria S., True, Lawrence, Wobker, Sara E., Yang, Ximing J., Zhou, Ming, Zynger, Debra L., Epstein, Jonathan I.

“…•GUPS survey: 834 clinician responses on practice patterns related to prostate cancer grading.•Includes % high-grade disease, cribriform/intraductal carcinoma,…”
Get full text